RareBase

The RareBase Networking Portal links people and companies throughout the world with an interest in rare and paediatric diseases. There are nearly 7,000 recognized rare diseases affecting nearly 30 million Americans and an estimated 350 million people worldwide. Most of these rare diseases are genetic and many appear early in life. Around 75 percent... of rare diseases affect children and 30 percent of rare disease patients will not live to the age of five. The vast majority of rare diseases have no approved treatment options and there is a critical need for new therapies. International collaboration will facilitate research and enhance treatment for those suffering from debilitating and often fatal disease. Our aim is to bring together individuals, organisations, industry and investors from across the globe to help realise this goal. Join our network today to find potential matches for research collaboration, investment or strategic partnerships. Subscription to the Networking Portal is open to individuals and companies who are actively engaged as stakeholders in the paediatric and rare disease market. All subscription applications are subject to a review and approval by the RareBase committee. Access to the Networking Portal, that allows search for potential partners, investors and alike within the industry. Database of our subscribers includes full contact information (email and direct phone numbers) of all the organisations and individuals. Provides full visibility of yours and your organisation`s needs and allows other subscribers to express an interest to collaborate with you. We offer 3 subscription options: Individuals who are actively engaged in any segment of the paediatric or rare disease market, either as volunteers, medical professionals, patient group representatives, advocates or similar, are welcome to subscribe to our Networking Portal without any charge. The individual subscription option will not allow subscribers to register with a company/organisation name. This option is open to academic ...Read More